Patterns of contact phase proteins indicating neuropathy in diabetic patients
- 18 Downloads
In 42 outpatients of the diabetology division, coagulation and fibrinolysis variables were determined in order to detect typical patterns of results with which it was possible to discriminate between three groups with different diabetic complications (17: no complication, 7: angiopathy alone, 18: neuropathy with or without other complications). There was a statistically significant discriminatory function involving C1-inhibitor concentration, high molecular weight kininogen coagulant activity and fibrinogen as the mosts decisive variables. The neuropathy group was appropriately separated from the others with an 81% correct reclassification. Heparin cofactor II, histidine-rich glycoprotein, α2-macroglobulin, pre-kallikrein and factor XII had no discriminative power.
Key wordsCoagulation factors Contact phase Fibrinolysis Diabetes mellitus Neuropathy
Unable to display preview. Download preview PDF.
- 2.Christe M, Fritschi J, Lämmle B, Tran TH, Marbet GA, Duckert F (1984) Fifteen coagulation and fibrinolysis parameters in diabetes mellitus and in patients with vasculopathy. Thromb Haemostas 52: 138–43Google Scholar
- 3.Christe M, Gattlen P, Fritschi J, Lämmle B, Marbet GA, Duckert F (1984) The contact phase of coagulation in diabetes mellitus and in patients with vasculopathy. Thromb Haemostas 52: 221–3Google Scholar
- 6.Ewing DJ, Clarke BF (1982) Diagnosis and management of diabetic autonomic neuropathy. Br Med J 285: 916–8Google Scholar
- 7.Fritschi J, Christe M, Lämmle B, Marbet GA, Berger W, Duckert F (1984) Platelet aggregation, β-thromboglobulin and platelet factor 4 in diabetes mellitus and in patients with vasculopathy. Thromb Haemostas 52: 236–9Google Scholar
- 13.Patrassi GM, Martinelli S, Picchinenna A, Girolami A (1985) Contact phase of coagulation in diabetes mellitus after aspirin administration. Folia Haematol 112: 333–338Google Scholar
- 15.Tran TH, Duckert F (1984) Heparin cofactor II determination — levels in normals and patients with hereditary antithrombin III deficiency and disseminated intravascular coagulation. Thromb Haemostas 52: 112–6Google Scholar